Highland Capital Management (Tennessee)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-5,030	Closed	-$468K	–	360
2017 Q3	$468K	Buy	5,030 +55	+1%	+$5.12K	0.04%	272
2017 Q2	$452K	Buy	+4,975	New	+$452K	0.04%	282
2015 Q3	–	Sell	-300	Closed	-$41K	–	666
2015 Q2	$41K	Buy	+300	New	+$41K	﹤0.01%	404